[Form 4] PRECIGEN, INC. Insider Trading Activity
Precigen, Inc. (PGEN)Randal J. Kirk on a Form 4. Through entity Kapital Joe, he sold 1,086,153 shares of common stock on 11/19/2025 at a weighted average price of $4.47, 942,832 shares on 11/20/2025 at a weighted average price of $4.08, and 937,308 shares on 11/21/2025 at $3.83.
The filing notes that the first two prices are weighted averages for multiple trades within reported price ranges, and Kirk undertakes to provide full trade details on request. After these sales, he continues to report large indirect beneficial ownership positions in Precigen through multiple entities, including 7,434,384 shares held by Kapital Joe and 82,164,767 shares held by R.J. Kirk Declaration of Trust, along with additional holdings through various family and investment vehicles.
- None.
- None.
Insights
Large insider sales by a 10% owner/director reduce direct exposure but leave substantial indirect holdings outstanding.
The filing shows that **Randal J. Kirk**, a **director** and **10% owner** of **Precigen, Inc. (PGEN)**, reported three open‑market sales of common stock on
Beyond Kapital Joe, the filing lists large additional indirect holdings in multiple entities, including **82,164,767** shares via **R.J. Kirk DOT** and multi‑million share positions in several other LLCs and partnerships, plus 6,085,471 shares via **Third Security, LLC** and 1,144,481 shares held by his spouse. All of these may be deemed beneficially owned under Rule 13d‑3, although he disclaims beneficial ownership except to the extent of any pecuniary interest. This means his economic exposure remains very significant even after the reported sales.
The concrete takeaway is a noticeable reduction in one indirect position, not an exit: a total of 2,966,293 shares were sold over three days, while aggregate indirect positions across entities remain large. The sales were executed over price ranges disclosed in the footnotes, and the weighted‑average disclosure suggests many small trades within those bands. A key item to watch over the next few quarters is whether similar Form 4 filings show continued net selling from these entities or a stable remaining stake.
FAQ
What insider transaction did PGEN report for Randal J. Kirk?
The Form 4 shows that Randal J. Kirk, a director and 10% owner of Precigen, Inc. (PGEN), reported sales of common stock on 11/19/2025, 11/20/2025, and 11/21/2025 through the entity Kapital Joe.
How many PGEN shares did Kapital Joe sell on 11/19/2025 and at what price?
On 11/19/2025, Kapital Joe sold 1,086,153 shares of PGEN common stock at a weighted average price of $4.47 per share, with individual trade prices ranging from $4.31 to $4.68.
What were the PGEN share sales on 11/20/2025 and 11/21/2025?
On 11/20/2025, Kapital Joe sold 942,832 shares at a weighted average price of $4.08, with trades between $3.90 and $4.42. On 11/21/2025, it sold 937,308 shares at $3.83 per share.
How many PGEN shares does Randal J. Kirk report owning after these transactions?
Following the reported sales, Randal J. Kirk reports indirect beneficial ownership of 7,434,384 shares through Kapital Joe and additional indirect holdings, including 82,164,767 shares through R.J. Kirk Declaration of Trust and other entities and family vehicles listed in the Form 4.
Through which entities does Randal J. Kirk hold indirect PGEN shares?
The filing states that Kirk controls entities including Kapital Joe, R.J. Kirk Declaration of Trust, Parkview 2020, several JPK, MGK, and ZSK LLCs, Kellie L. Banks LTT, Lotus, Sunset 2020, and Third Security, and that shares held by these entities may be deemed beneficially owned by him.
Does Randal J. Kirk claim full beneficial ownership of all indirectly held PGEN shares?
The Form 4 notes that shares held by the listed entities may be deemed beneficially owned by Randal J. Kirk under Rule 13d-3, but he disclaims beneficial ownership of such shares except to the extent of any pecuniary interest.